Irisin — a new biomarker for endometrial cancer?
Ginekologia Polska · 2025
DOI: 10.5603/gpl.104455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ginekologia Polska, 2025. Verfasst von Monika Szarszewska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Gynaecological Oncology, Poznan University of Medical Sciences, Poznan, Poland. monika.szarszewska@gmail.com. Hauptthemen laut MEDLINE: Fibronectins, Endometrial Neoplasms, Biomarkers, Tumor.
Abstract (Originalsprache)
Objectives
Irisin is an adipomyokine that has an inhibitory effect on inflammation and possesses anticancer activity. It inhibits cancer cell proliferation, metastasis, and invasion through various signaling pathways associated with carcinogenesis. It has been described to be associated with a number of malignancies in various locations. It has been recognized that it may be a biomarker and prognostic factor in some malignancies. In addition, studies indicate irisin's possible role in treating malignant lesions. Material and methods: In material including 129 cases of endometrial cancer and normal endometrium in a control group of 18 women with uterine myomas.
Results
There were no statistical differences in irisin protein expression. There were also no differences in irisin expression according to clinical stage, type, and histopathological differentiation.
Conclusions
Further clinical studies are needed to evaluate irisin activity in endometrial cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Gynaecological Oncology, Poznan University of Medical Sciences, Poznan, Poland. monika.szarszewska@gmail.com.
- Gynecological Center, Poznan, Poland, Poland.
- Faculty of Health Sciences University of Opole, Poland.
- Faculty of Nursing and Midwifery Department of Obstetrics Department of Specialist Care in Obstetrics and Gynecology Wroclaw Medical University, Wroclaw, Poland.
- Department of Tumour Pathology and Prophylaxis Poznan University of Medical Sciences, Greater Poland Cancer Centre, Poznan, Poland, Poland.
- Department of Computer Science and Statistics, Poznan University of Medical Sciences, Poznan, Poland, Poland.
Zitieren
APA
Szarszewska, M., Markowska, J., Grybos, M., Grybos, A., Marszalek, A., Malicka-Durczak, A., Filas, V., Michalak, M., & Markowska, A. (2025). Irisin — a new biomarker for endometrial cancer?. Ginekologia Polska. https://doi.org/10.5603/gpl.104455
Vancouver
Szarszewska M, Markowska J, Grybos M, Grybos A, Marszalek A, Malicka-Durczak A, et al. Irisin — a new biomarker for endometrial cancer?. Ginekologia Polska. 2025. doi:10.5603/gpl.104455
BibTeX
@article{Szarszewska2025,
author = {Szarszewska, Monika and Markowska, Janina and Grybos, Marian and Grybos, Anna and Marszalek, Andrzej and Malicka-Durczak, Anna and Filas, Violetta and Michalak, Michal and Markowska, Anna},
title = {Irisin — a new biomarker for endometrial cancer?},
journal = {Ginekologia Polska},
year = {2025},
doi = {10.5603/gpl.104455}
}
EUVIMED